EP3755362
MC4R AGONIST EFFICACY IN SUBJECTS WITH MC4R DEFICIENCIES AND IMPAIRED NFAT SIGNALING
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.2.2019EP published:
19.11.2025EP application number:
19707740.7
EPO information:
European Patent Register
Max expiry date:
19.2.2039
Title in English:
MC4R AGONIST EFFICACY IN SUBJECTS WITH MC4R DEFICIENCIES AND IMPAIRED NFAT SIGNALINGLanguage of the patent:
English
Timeline
Today
20.2.2019EP application
19.11.2025EP Publication
Owner
Name:
Charité - Universitätsmedizin BerlinAddress:
Charitéplatz 1, 10117 Berlin, DE
Inventor
Name:
KÜHNEN, PeterAddress:
13465 Berlin, DE
Name:
BIEBERMANN, HeikeAddress:
12105 Berlin, DE
Name:
KRUDE, HeikoAddress:
10589 Berlin, DE
Priority
Number:
18157739Date:
20.2.2018Country:
EP
Number:
18168228Date:
19.4.2018Country:
EP
Classification
Categories:
A61K 38/12, A61P 3/04, G01N 33/48, G01N 33/68